Loading…

Dissolution behavior of various drugs in different FaSSIF versions

Biorelevant media have proven to be useful in predicting the performance of poorly soluble drugs in the gastrointestinal tract. Several versions of fasted state simulated intestinal fluids have been published and compared with respect to their physical chemical properties and solubilization of drugs...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmaceutical sciences 2020-01, Vol.142, p.105138-105138, Article 105138
Main Authors: Klumpp, Lukas, Leigh, Mathew, Dressman, Jennifer
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c422t-838414a5a020c5a1f7a97288654627ad84778ee46dbe214309e6a85fb6f647e23
cites cdi_FETCH-LOGICAL-c422t-838414a5a020c5a1f7a97288654627ad84778ee46dbe214309e6a85fb6f647e23
container_end_page 105138
container_issue
container_start_page 105138
container_title European journal of pharmaceutical sciences
container_volume 142
creator Klumpp, Lukas
Leigh, Mathew
Dressman, Jennifer
description Biorelevant media have proven to be useful in predicting the performance of poorly soluble drugs in the gastrointestinal tract. Several versions of fasted state simulated intestinal fluids have been published and compared with respect to their physical chemical properties and solubilization of drugs. However, to date there have been no reports in the literature comparing dissolution of poorly soluble drugs in these media. In this study eleven BCS Class II compounds (five nonionized compounds, three weak bases and three weak acids) were investigated with respect to their thermodynamic solubility and dissolution behavior in three biorelevant media simulating conditions in the small intestine (FaSSIF V1, FaSSIF V2 and FaSSIF V3). It was shown that the maximum percentage release of drugs from their commercial formulations can differ from the results for the thermodynamic solubility of the pure drug; these differences can be largely attributed to API presentation, composition of the formulation and manufacturing effects. The results were additionally compared with data for solubility in HIF taken from the literature in order to determine which version of FaSSIF most closely corresponds to the physiological conditions. The different versions of FaSSIF are able to achieve solubility results similar to those in HIF, with closest results generally achieved in FaSSIF V1. The magnitude of solubility/dissolution differences among the three FaSSIF versions is dependent on the drug's characteristics. In the case of weakly basic compounds, the differences among the FaSSIF versions are minor. For weakly acidic compounds the behavior in the different versions is primarily pH dependent and influenced by the lipid composition of the FaSSIF only to a minor extent. The differences in solubility and dissolution of the nonionized compounds among the three versions of FaSSIF becomes apparent above a log P value of 2.5, with larger differences among the versions at high log P values. [Display omitted]
doi_str_mv 10.1016/j.ejps.2019.105138
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2313358092</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0928098719304117</els_id><sourcerecordid>2313358092</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-838414a5a020c5a1f7a97288654627ad84778ee46dbe214309e6a85fb6f647e23</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EouXxAyyQl2xS_ErsSGygUKhUiUVhbTnJBBy1cbGTSPw9rlJYshppdO7VzEHoipIZJTS7bWbQ7MKMEZrHRUq5OkJTqmSeEMnIMZqSnKmE5EpO0FkIDSEkU5KcogmnkgguxBQ9PNoQ3KbvrGtxAZ9msM5jV-PBeOv6gCvffwRsW1zZugYPbYcXZr1eLvAAPsRUuEAntdkEuDzMc_S-eHqbvySr1-fl_H6VlIKxLlFcCSpMaggjZWpoLU0umVJZKjImTaWElApAZFUBjApOcsiMSusiqzMhgfFzdDP27rz76iF0emtDCZuNaSFeqhmnnKcqPh1RNqKldyF4qPXO263x35oSvXenG713p_fu9Oguhq4P_X2xheov8isrAncjAPHLwYLXobTQllBZD2WnK2f_6_8BiUl-cA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2313358092</pqid></control><display><type>article</type><title>Dissolution behavior of various drugs in different FaSSIF versions</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Klumpp, Lukas ; Leigh, Mathew ; Dressman, Jennifer</creator><creatorcontrib>Klumpp, Lukas ; Leigh, Mathew ; Dressman, Jennifer</creatorcontrib><description>Biorelevant media have proven to be useful in predicting the performance of poorly soluble drugs in the gastrointestinal tract. Several versions of fasted state simulated intestinal fluids have been published and compared with respect to their physical chemical properties and solubilization of drugs. However, to date there have been no reports in the literature comparing dissolution of poorly soluble drugs in these media. In this study eleven BCS Class II compounds (five nonionized compounds, three weak bases and three weak acids) were investigated with respect to their thermodynamic solubility and dissolution behavior in three biorelevant media simulating conditions in the small intestine (FaSSIF V1, FaSSIF V2 and FaSSIF V3). It was shown that the maximum percentage release of drugs from their commercial formulations can differ from the results for the thermodynamic solubility of the pure drug; these differences can be largely attributed to API presentation, composition of the formulation and manufacturing effects. The results were additionally compared with data for solubility in HIF taken from the literature in order to determine which version of FaSSIF most closely corresponds to the physiological conditions. The different versions of FaSSIF are able to achieve solubility results similar to those in HIF, with closest results generally achieved in FaSSIF V1. The magnitude of solubility/dissolution differences among the three FaSSIF versions is dependent on the drug's characteristics. In the case of weakly basic compounds, the differences among the FaSSIF versions are minor. For weakly acidic compounds the behavior in the different versions is primarily pH dependent and influenced by the lipid composition of the FaSSIF only to a minor extent. The differences in solubility and dissolution of the nonionized compounds among the three versions of FaSSIF becomes apparent above a log P value of 2.5, with larger differences among the versions at high log P values. [Display omitted]</description><identifier>ISSN: 0928-0987</identifier><identifier>EISSN: 1879-0720</identifier><identifier>DOI: 10.1016/j.ejps.2019.105138</identifier><identifier>PMID: 31704344</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>BCS II ; Biorelevant media ; Dissolution ; FaSSIF ; Human intestinal media ; Solubility</subject><ispartof>European journal of pharmaceutical sciences, 2020-01, Vol.142, p.105138-105138, Article 105138</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-838414a5a020c5a1f7a97288654627ad84778ee46dbe214309e6a85fb6f647e23</citedby><cites>FETCH-LOGICAL-c422t-838414a5a020c5a1f7a97288654627ad84778ee46dbe214309e6a85fb6f647e23</cites><orcidid>0000-0001-9066-3980 ; 0000-0001-9719-9148</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31704344$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Klumpp, Lukas</creatorcontrib><creatorcontrib>Leigh, Mathew</creatorcontrib><creatorcontrib>Dressman, Jennifer</creatorcontrib><title>Dissolution behavior of various drugs in different FaSSIF versions</title><title>European journal of pharmaceutical sciences</title><addtitle>Eur J Pharm Sci</addtitle><description>Biorelevant media have proven to be useful in predicting the performance of poorly soluble drugs in the gastrointestinal tract. Several versions of fasted state simulated intestinal fluids have been published and compared with respect to their physical chemical properties and solubilization of drugs. However, to date there have been no reports in the literature comparing dissolution of poorly soluble drugs in these media. In this study eleven BCS Class II compounds (five nonionized compounds, three weak bases and three weak acids) were investigated with respect to their thermodynamic solubility and dissolution behavior in three biorelevant media simulating conditions in the small intestine (FaSSIF V1, FaSSIF V2 and FaSSIF V3). It was shown that the maximum percentage release of drugs from their commercial formulations can differ from the results for the thermodynamic solubility of the pure drug; these differences can be largely attributed to API presentation, composition of the formulation and manufacturing effects. The results were additionally compared with data for solubility in HIF taken from the literature in order to determine which version of FaSSIF most closely corresponds to the physiological conditions. The different versions of FaSSIF are able to achieve solubility results similar to those in HIF, with closest results generally achieved in FaSSIF V1. The magnitude of solubility/dissolution differences among the three FaSSIF versions is dependent on the drug's characteristics. In the case of weakly basic compounds, the differences among the FaSSIF versions are minor. For weakly acidic compounds the behavior in the different versions is primarily pH dependent and influenced by the lipid composition of the FaSSIF only to a minor extent. The differences in solubility and dissolution of the nonionized compounds among the three versions of FaSSIF becomes apparent above a log P value of 2.5, with larger differences among the versions at high log P values. [Display omitted]</description><subject>BCS II</subject><subject>Biorelevant media</subject><subject>Dissolution</subject><subject>FaSSIF</subject><subject>Human intestinal media</subject><subject>Solubility</subject><issn>0928-0987</issn><issn>1879-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EouXxAyyQl2xS_ErsSGygUKhUiUVhbTnJBBy1cbGTSPw9rlJYshppdO7VzEHoipIZJTS7bWbQ7MKMEZrHRUq5OkJTqmSeEMnIMZqSnKmE5EpO0FkIDSEkU5KcogmnkgguxBQ9PNoQ3KbvrGtxAZ9msM5jV-PBeOv6gCvffwRsW1zZugYPbYcXZr1eLvAAPsRUuEAntdkEuDzMc_S-eHqbvySr1-fl_H6VlIKxLlFcCSpMaggjZWpoLU0umVJZKjImTaWElApAZFUBjApOcsiMSusiqzMhgfFzdDP27rz76iF0emtDCZuNaSFeqhmnnKcqPh1RNqKldyF4qPXO263x35oSvXenG713p_fu9Oguhq4P_X2xheov8isrAncjAPHLwYLXobTQllBZD2WnK2f_6_8BiUl-cA</recordid><startdate>20200115</startdate><enddate>20200115</enddate><creator>Klumpp, Lukas</creator><creator>Leigh, Mathew</creator><creator>Dressman, Jennifer</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9066-3980</orcidid><orcidid>https://orcid.org/0000-0001-9719-9148</orcidid></search><sort><creationdate>20200115</creationdate><title>Dissolution behavior of various drugs in different FaSSIF versions</title><author>Klumpp, Lukas ; Leigh, Mathew ; Dressman, Jennifer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-838414a5a020c5a1f7a97288654627ad84778ee46dbe214309e6a85fb6f647e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>BCS II</topic><topic>Biorelevant media</topic><topic>Dissolution</topic><topic>FaSSIF</topic><topic>Human intestinal media</topic><topic>Solubility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klumpp, Lukas</creatorcontrib><creatorcontrib>Leigh, Mathew</creatorcontrib><creatorcontrib>Dressman, Jennifer</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klumpp, Lukas</au><au>Leigh, Mathew</au><au>Dressman, Jennifer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dissolution behavior of various drugs in different FaSSIF versions</atitle><jtitle>European journal of pharmaceutical sciences</jtitle><addtitle>Eur J Pharm Sci</addtitle><date>2020-01-15</date><risdate>2020</risdate><volume>142</volume><spage>105138</spage><epage>105138</epage><pages>105138-105138</pages><artnum>105138</artnum><issn>0928-0987</issn><eissn>1879-0720</eissn><abstract>Biorelevant media have proven to be useful in predicting the performance of poorly soluble drugs in the gastrointestinal tract. Several versions of fasted state simulated intestinal fluids have been published and compared with respect to their physical chemical properties and solubilization of drugs. However, to date there have been no reports in the literature comparing dissolution of poorly soluble drugs in these media. In this study eleven BCS Class II compounds (five nonionized compounds, three weak bases and three weak acids) were investigated with respect to their thermodynamic solubility and dissolution behavior in three biorelevant media simulating conditions in the small intestine (FaSSIF V1, FaSSIF V2 and FaSSIF V3). It was shown that the maximum percentage release of drugs from their commercial formulations can differ from the results for the thermodynamic solubility of the pure drug; these differences can be largely attributed to API presentation, composition of the formulation and manufacturing effects. The results were additionally compared with data for solubility in HIF taken from the literature in order to determine which version of FaSSIF most closely corresponds to the physiological conditions. The different versions of FaSSIF are able to achieve solubility results similar to those in HIF, with closest results generally achieved in FaSSIF V1. The magnitude of solubility/dissolution differences among the three FaSSIF versions is dependent on the drug's characteristics. In the case of weakly basic compounds, the differences among the FaSSIF versions are minor. For weakly acidic compounds the behavior in the different versions is primarily pH dependent and influenced by the lipid composition of the FaSSIF only to a minor extent. The differences in solubility and dissolution of the nonionized compounds among the three versions of FaSSIF becomes apparent above a log P value of 2.5, with larger differences among the versions at high log P values. [Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>31704344</pmid><doi>10.1016/j.ejps.2019.105138</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-9066-3980</orcidid><orcidid>https://orcid.org/0000-0001-9719-9148</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0928-0987
ispartof European journal of pharmaceutical sciences, 2020-01, Vol.142, p.105138-105138, Article 105138
issn 0928-0987
1879-0720
language eng
recordid cdi_proquest_miscellaneous_2313358092
source ScienceDirect Freedom Collection 2022-2024
subjects BCS II
Biorelevant media
Dissolution
FaSSIF
Human intestinal media
Solubility
title Dissolution behavior of various drugs in different FaSSIF versions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A30%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dissolution%20behavior%20of%20various%20drugs%20in%20different%20FaSSIF%20versions&rft.jtitle=European%20journal%20of%20pharmaceutical%20sciences&rft.au=Klumpp,%20Lukas&rft.date=2020-01-15&rft.volume=142&rft.spage=105138&rft.epage=105138&rft.pages=105138-105138&rft.artnum=105138&rft.issn=0928-0987&rft.eissn=1879-0720&rft_id=info:doi/10.1016/j.ejps.2019.105138&rft_dat=%3Cproquest_cross%3E2313358092%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-838414a5a020c5a1f7a97288654627ad84778ee46dbe214309e6a85fb6f647e23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2313358092&rft_id=info:pmid/31704344&rfr_iscdi=true